| Nov 5 |
Kymera Therapeutics to Participate in Upcoming November Investor Conferences
|
| Nov 4 |
Analysts Have Made A Financial Statement On Kymera Therapeutics, Inc.'s (NASDAQ:KYMR) Third-Quarter Report
|
| Nov 3 |
Kymera Therapeutics, Inc. (KYMR) Q3 2024 Earnings Call Transcript
|
| Nov 1 |
Kymera Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
|
| Nov 1 |
Kymera Q3 Loss Narrower Than Expected, Pipeline in Focus
|
| Nov 1 |
Kymera Therapeutics Inc (KYMR) Q3 2024 Earnings Call Highlights: Strategic Advancements and ...
|
| Nov 1 |
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners
|
| Oct 31 |
Kymera Therapeutics, Inc. (KYMR) Reports Q3 Loss, Lags Revenue Estimates
|
| Oct 31 |
Kymera Therapeutics GAAP EPS of -$0.82 beats by $0.02, revenue of $3.74M misses by $6.6M
|
| Oct 31 |
Kymera Therapeutics Announces Third Quarter 2024 Financial Results and Provides a Business Update
|
